Treatment-emergent mutations in myelodysplastic syndrome with del(5q) – lenalidomide related or disease-intrinsic clonal evolution?

Mostafa Abdallah; Kaaren Reichard; Naseema Gangat; Ayalew Tefferi

doi:10.1038/s41408-024-01027-5

Treatment-emergent mutations in myelodysplastic syndrome with del(5q) – lenalidomide related or disease-intrinsic clonal evolution?

Mostafa Abdallah, Kaaren Reichard, Naseema Gangat, Ayalew Tefferi

Hematology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Article number	49
Journal	Blood cancer journal
Volume	14
Issue number	1
DOIs	https://doi.org/10.1038/s41408-024-01027-5
State	Published - Dec 2024

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1038/s41408-024-01027-5

Cite this

@article{b50b1989e61c4b52858f454b14579a9b,

title = "Treatment-emergent mutations in myelodysplastic syndrome with del(5q) – lenalidomide related or disease-intrinsic clonal evolution?",

author = "Mostafa Abdallah and Kaaren Reichard and Naseema Gangat and Ayalew Tefferi",

year = "2024",

month = dec,

doi = "10.1038/s41408-024-01027-5",

language = "English (US)",

volume = "14",

journal = "Blood cancer journal",

issn = "2044-5385",